Besides being up-regulated in a variety of tumors, VEGFR-1 is expressed in monocyte/macrophages and involved in their recruitment to the tumor sites, where they secrete pro-angiogenic factors that further stimulate tumor growth and contribute to resistance to anti-VEGF-A therapies [37–39]. This evidence concerns the gene FLT1 and neoplasm.